Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
58.02
-0.27 (-0.46%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Hologic Employees
Hologic had 6,990 employees as of September 30, 2023. The number of employees increased by 46 or 0.66% compared to the previous year.
Employees
6,990
Change (1Y)
46
Growth (1Y)
0.66%
Revenue / Employee
$577,825
Profits / Employee
$106,438
Market Cap
13.02B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 6,990 | 46 | 0.66% |
Sep 24, 2022 | 6,944 | 239 | 3.56% |
Sep 25, 2021 | 6,705 | 891 | 15.33% |
Sep 26, 2020 | 5,814 | -664 | -10.25% |
Sep 28, 2019 | 6,478 | 226 | 3.61% |
Sep 29, 2018 | 6,252 | 19 | 0.30% |
Sep 30, 2017 | 6,233 | 900 | 16.88% |
Sep 24, 2016 | 5,333 | 43 | 0.81% |
Sep 26, 2015 | 5,290 | -61 | -1.14% |
Sep 27, 2014 | 5,351 | -264 | -4.70% |
Sep 28, 2013 | 5,615 | -542 | -8.80% |
Sep 29, 2012 | 6,157 | 1,138 | 22.67% |
Sep 24, 2011 | 5,019 | 799 | 18.93% |
Sep 25, 2010 | 4,220 | 261 | 6.59% |
Sep 26, 2009 | 3,959 | 26 | 0.66% |
Oct 25, 2008 | 3,933 | 353 | 9.86% |
Nov 12, 2007 | 3,580 | 1,963 | 121.40% |
Nov 17, 2006 | 1,617 | 747 | 85.86% |
Nov 19, 2005 | 870 | 109 | 14.32% |
Nov 30, 2004 | 761 | 39 | 5.40% |
Nov 30, 2003 | 722 | -7 | -0.96% |
Nov 30, 2002 | 729 | -51 | -6.54% |
Nov 30, 2001 | 780 | -66 | -7.80% |
Nov 30, 2000 | 846 | 410 | 94.04% |
Nov 30, 1999 | 436 | 40 | 10.10% |
Nov 30, 1998 | 396 | 57 | 16.81% |
Nov 30, 1997 | 339 | 45 | 15.31% |
Nov 30, 1996 | 294 | 103 | 53.93% |
Nov 30, 1995 | 191 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
HOLX News
- 2 days ago - Cellulite Treatment Market Trends, Growth Opportunities and Shares 2025-2030; Featuring Key Players - Hologic (Cynosure), Merz Pharma, Syneron Medical, Zimmer Aesthetics & More - GlobeNewsWire
- 3 days ago - Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI - Business Wire
- 5 days ago - Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report - Business Wire
- 23 days ago - Wayde McMillan Elected to Hologic Board of Directors - Business Wire
- 24 days ago - Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025 - Business Wire
- 2 months ago - Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference - Business Wire
- 2 months ago - Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software - Business Wire
- 2 months ago - Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay - Business Wire